Affiliation:
1. Faculdade de Farmácia, UFRGS Porto Alegre Rio Grande do Sul Brazil
2. Serviço de Genética Médica, HCPA, UFRGS Porto Alegre Rio Grande do Sul Brazil
3. Residência em Análises Clínicas do Hospital de Clínicas de Porto Alegre Porto Alegre Rio Grande do Sul Brazil
4. Programa de Pós‐Graduação em Ciências Biológicas: Bioquímica, UFRGS Porto Alegre Rio Grande do Sul Brazil
5. Programa de Pós‐Graduação em Ciências Farmacêuticas Porto Alegre Rio Grande do Sul Brazil
Abstract
AbstractMaple syrup urine disease (MSUD) is caused by a deficiency in the activity of the branched‐chain α‐ketoacid dehydrogenase (BCKD) complex, promoting the accumulation of the branched‐chain amino acids (BCAA) leucine, isoleucine, and valine, as well as their respective α‐keto acids. MSUD is an autosomal recessive hereditary metabolic disorder characterized by ketoacidosis, ataxia, coma, and mental and psychomotor retardation. The mechanisms involved in the brain damage caused by MSUD are not fully understood. Early diagnosis and treatment, as well as proper control of metabolic decompensation crises, are crucial for patients' survival and for a better prognosis. The recommended treatment consists of a high‐calorie diet with restricted protein intake and specific formulas containing essential amino acids, except those accumulated in MSUD. This treatment will be maintained throughout life, being adjusted according to the patients' nutritional needs and BCAA concentration. Because dietary treatment may not be sufficient to prevent neurological damage in MSUD patients, other therapeutic strategies have been studied, including liver transplantation. With transplantation, it is possible to obtain an increase of about 10% of the normal BCKD in the body, an amount sufficient to maintain amino acid homeostasis and reduce metabolic decompensation crises. However, the experience related to this practice is very limited when considering the shortage of liver for transplantation and the risks related to the surgical procedure and immunosuppression. Thus, the purpose of this review is to survey the benefits, risks, and challenges of liver transplantation in the treatment of MSUD.
Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Hospital de Clínicas de Porto Alegre
Subject
Developmental Biology,Developmental Neuroscience
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献